anti-Pseudomonas aeruginosa IgG ELISA

Este producto es parte de ADAMTS5 - ADAM metallopeptidase with thrombospondin type 1 motif 5
Product Graph
2048€ (3 x 96 det.)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
anti-Pseudomonas aeruginosa IgG ELISA
category
ELISA Kits
provider
Mediagnost
reference
E15
tested applications
Elisa

Description

The Mediagnost Anti-Pseudomonas aeruginosa IgG ELISA (Ref: E15), is an enzyme immunoassay for qualitative and quantitative detection of IgG-Antibodies in human serum against the extracellular proteins: Alkaline Protease (AP), Elastase (ELA) and Exotoxin A (Exo A) of Pseudomonas aeruginosa.

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
ELISA Kits
Reactivity
Human
Assay Data
Reference Material: not available
Incubation Period: 4.5 h
Calibrator: positive human serum
Assay Type
sandwich
Test Range
0.2 – 2500 [titer/mL]
Sensitivity
< 0.2 [Titre/mL]
Recommended Dilution
1:1000/ 1:10000/ 1:100000
Origin
Antibody: alkaline protease Elastase Exotoxin A
Size 1
3 x 96 det.
Tested Applications
Elisa
Sample Type
Serum / EDTA plasma
Availability
3-5 days.
Storage
Shelf life: between 1 and 2 years.
Store the kit at 2-8°C until its expiry date.
Background
Elisa Kits for: Pseudomonas
Status
IVD
Note
Intra/Interassay Variance [%]< 20% for titers > 1250

Descripción

Anti-Pseudomonas aeruginosa IgG  Elisa kit de Mediagnost (Ref: E15), es un inmunoensayo enzimático para la detección cualitativa y cuantitativa de anticuerpos IgG en suero humano contra las proteínas extracelulares: proteasa alcalina (AP), elastasa (ELA) y exotoxina A (Exo A) de Pseudomonas aeruginosa.

Pseudomonas aeruginosa, a Gram-negative bacterium ubiquitously distributed in the moist environment, causes about 10% of all nosocomial infections. This opportunistic pathogen leads to acute and chronic types of infection within various organs of susceptible patient groups. Chronic pulmonary infection in patients with cystic fibrosis (CF) is very frequent, may start early in infancy and determines the life expectancy of these patients. P. aeruginosa infection provokes a production of antibodies to a large number of P. aeruginosa antigens in CF patients. Mediagnost’s sensitive antibody detection system is an aid to discriminate between infected and uninfected patient groups. Thus, the test is a supplement of microbiological diagnostics, which can be influenced by sampling technique (e.g. throat swab). Depending on the Pseudomonas aeruginosa species and the patient’s immune reaction, antibodies can be detected against a single, two or even all three antigens simultaneously. A patient is regarded as sero-positive when the serum is positive for one or more of the antigens.

Related Products

E10

Anti-HAV ELISA

Mediagnost anti-HAV ELISA, (Ref: E10) is an enzyme immunoassay for the detection of antibodies against Hepatitis A virus in Human Serum for research use.

Ver Producto
E11

Anti-HAV IgM ELISA

The Mediagnost anti-HAV IgM ELISA is a "class-capture" enzyme immuoassay. Serum or plasma samples are diluted 1:2000 and added to the wells of a microtiter plate, which have been previously coated with an antibody directed against human IgM antibodies (µ-chain specific). All IgM antibodies present in the sample are bound during an incubation step. After washing, the Hepatitis A-virus is added, which binds only to the HAV-specific IgM antibodies. The bound antigen is detected by the addition of the conjugate (monoclonal anti-HAV antibody, peroxidase conjugated). After washing and incubation with a colorimetric substrate the reaction is terminated by addition of stop solution and the color turns to yellow. The absorbance of the coloured reaction product is measured on a microtiter plate reader. The colour intensity of the reaction corresponds to the concentration of antibodies in the sample

Ver Producto
E12

Hepatitis A-Virus Antigen (HAV) ELISA

Enzyme immunoassay for the qualitative detection of hepatitis A virus antigen in human stool specimens.Early detection of HAV antigen in stool samples from patients with gastrointestinal disease allows rapid establishment of hygiene measures, preventing further spread of the virus.

Ver Producto